DalsnaFinance › IPOs › Verrica Pharmaceuticals › IPO
Verrica Pharmaceuticals Inc. completed its initial public offering on NASDAQ on June 15, 2018, pricing at $15.00 a share.
| Ticker | VRCA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 15, 2018 |
| Offering price | $15.00 |
| Shares offered | 5,000,000 |
| Total raised | $75M |
Verrica Pharmaceuticals Inc. sold 5,000,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $75 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $75 million total recorded for the deal.
Verrica Pharmaceuticals Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Verrica Pharmaceuticals Inc.. This page is general information, not investment advice.